Literature DB >> 26313707

The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections.

Alice J Hsu1, Karen C Carroll2, Aaron M Milstone3, Edina Avdic1, Sara E Cosgrove4, Mercedes Vilasoa5, Pranita D Tamma3.   

Abstract

Combination antibiograms can be used to evaluate organism cross-resistance among multiple antibiotics. As combination therapy is generally favored for the treatment of carbapenemase-producing Enterobacteriaceae (CPE), combination antibiograms provide valuable information about the combination of antibiotics that achieve the highest likelihood of adequate antibiotic coverage against CPE.

Mesh：

Substances：

Year:  2015        PMID： 26313707     DOI： 10.1017/ice.2015.196

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  4 in total

1.  Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.

Authors:  P Garcinuño; M Santibañez; L Gimeno; A Sánchez-Bautista; J Coy; J Sánchez-Paya; V Boix; E Merino; J Portilla; J C Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-09       Impact factor: 3.267

2.  Biographical Feature: Karen C. Carroll, M.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

3.  Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.

Authors:  Vincenzo Scaglione; Mariaconcetta Reale; Chiara Davoli; Maria Mazzitelli; Francesca Serapide; Rosaria Lionello; Valentina La Gamba; Paolo Fusco; Andrea Bruni; Daniela Procopio; Eugenio Garofalo; Federico Longhini; Nadia Marascio; Cinzia Peronace; Aida Giancotti; Luigia Gallo; Giovanni Matera; Maria Carla Liberto; Bruno Mario Cesana; Chiara Costa; Enrico Maria Trecarichi; Angela Quirino; Carlo Torti
Journal:  Microb Drug Resist       Date:  2021-12-15       Impact factor: 2.706

Review 4.  Developmental roadmap for antimicrobial susceptibility testing systems.

Authors:  Alex van Belkum; Till T Bachmann; Gerd Lüdke; Jan Gorm Lisby; Gunnar Kahlmeter; Allan Mohess; Karsten Becker; John P Hays; Neil Woodford; Konstantinos Mitsakakis; Jacob Moran-Gilad; Jordi Vila; Harald Peter; John H Rex; Wm Michael Dunne
Journal:  Nat Rev Microbiol       Date:  2019-01       Impact factor: 60.633
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.